Concepedia

Author

Kyle Kuszpit

Pfizer (United States)

Also Known As

K. K. Kuszpit, KYLE KUSZPIT, Kyle K. Kuszpit, Kyle Kuszpit

40

Publications

725

Citations

14

H-Index

36

Concepts

All Affiliations

Pfizer (United States)University of MichiganUnited States Army Medical Research Institute of Infectious Diseases
KK

About

Kyle Kuszpit is an author at Pfizer (United States) specializing in magnetic resonance imaging, engineering, and medicine.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Engineering

3

3

176

2

Medicine

3

3

225

3

Health Sciences

1

1

58

4

Biochemistry

1

1

33

5

Biomedical Engineering

1

1

77

Kyle Kuszpit

×

15

Publications

696

Citations

14

H-Index

YearCitations

Neuropathogenesis of Zika Virus in a Highly Susceptible Immunocompetent Mouse Model after Antibody Blockade of Type I Interferon

Darci R. Smith, Bradley S. Hollidge, Sharon P. Daye,

PLoS neglected tropical diseases

2017

107

A Methodology for Registration of a Histological Slide and In Vivo MRI Volume Based on Optimizing Mutual Information

Charles R. Meyer, Bradford A. Moffat, Kyle Kuszpit,

Molecular Imaging

2006

77

[18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells

Cathy C. Zhang, Zhengming Yan, Wenlin Li,

Clinical Cancer Research

2011

76

PF-03732010: A Fully Human Monoclonal Antibody against P-Cadherin with Antitumor and Antimetastatic Activity

Cathy C. Zhang, Zhengming Yan, Qin Zhang,

Clinical Cancer Research

2010

74

Sodium and proton diffusion MRI as biomarkers for early therapeutic response in subcutaneous tumors

Victor D. Schepkin, Thomas L. Chenevert, Kyle Kuszpit,

Magnetic Resonance Imaging

2006

58

PF-00477736 Mediates Checkpoint Kinase 1 Signaling Pathway and Potentiates Docetaxel-Induced Efficacy in Xenografts

Cathy Zhang, Zhengming Yan, Cory L. Painter,

Clinical Cancer Research

2009

57

Proton and sodium MRI assessment of emerging tumor chemotherapeutic resistance

Victor D. Schepkin, Kuei C. Lee, Kyle Kuszpit,

NMR in Biomedicine

2006

41

Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice

Michael R. Kilbourn, Kyle Kuszpit, Phillip Sherman

Synapse

2000

40

The Discovery of a Novel Phosphodiesterase (PDE) 4B-Preferring Radioligand for Positron Emission Tomography (PET) Imaging

Lei Zhang, Laigao Chen, Elizabeth M. Beck,

Journal of Medicinal Chemistry

2017

35

The synthesis and in vivo evaluation of [18F]PF-9811: a novel PET ligand for imaging brain fatty acid amide hydrolase (FAAH)

Marc B. Skaddan, Lei Zhang, Douglas S. Johnson,

Nuclear Medicine and Biology

2012

33

Page 1